Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142147 |
| CAS No | NA |
| Mol.F. | C28H31ClN8O2 |
| Mol.Wt. | 547.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142148 |
| CAS No | 41286-73-1 |
| Mol.F. | C11H14N6O5 |
| Mol.Wt. | 310.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142149 |
| CAS No | NA |
| Mol.F. | C70H103N2O47S7 |
| Mol.Wt. | 1949.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142150 |
| CAS No | NA |
| Mol.F. | C70H110N2O47S7 |
| Mol.Wt. | 1956.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142151 |
| CAS No | NA |
| Mol.F. | C5H4N6O |
| Mol.Wt. | 164.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142152 |
| CAS No | NA |
| Mol.F. | C9H11N3O7 |
| Mol.Wt. | 273.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142153 |
| CAS No | NA |
| Mol.F. | C16H19N9O6 |
| Mol.Wt. | 433.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142154 |
| CAS No | NA |
| Mol.F. | C11H15N7O5 |
| Mol.Wt. | 325.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142155 |
| CAS No | NA |
| Mol.F. | C9H8N6O3 |
| Mol.Wt. | 248.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142156 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142157 |
| CAS No | NA |
| Mol.F. | C18H20N2O3 |
| Mol.Wt. | 312.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142158 |
| CAS No | 3006789-99-4 |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142159 |
| CAS No | NA |
| Mol.F. | C9H10N2O4 |
| Mol.Wt. | 210.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142160 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142161 |
| CAS No | NA |
| Mol.F. | C15H14N2O4 |
| Mol.Wt. | 286.29g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142162 |
| CAS No | NA |
| Mol.F. | C10H14N2O4 |
| Mol.Wt. | 226.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |